Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care



Status:Completed
Conditions:Lung Cancer, Colorectal Cancer, Cancer, Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:4/7/2017
Start Date:January 2013
End Date:July 2015

Use our guide to learn which trials are right for you!

Adherence to NCCN Survivorship Care Guidelines in Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care

This clinical trial studies adherence to survivorship care guidelines in health care
providers for non-small cell lung cancer or colorectal cancer survivor care. The completion
of an educational intervention by health care providers may increase compliance and
adherence to National Comprehensive Cancer Network guidelines for survivorship care.

PRIMARY OBJECTIVES:

I. To evaluate adherence of oncology health care providers to National Comprehensive Cancer
Network (NCCN) guidelines for cancer survivorship care in colorectal cancer (CRC) and
non-small cell lung cancer (NSCLC) cancers.

SECONDARY OBJECTIVES:

I. To develop and assess a targeted educational initiative to improve compliance with NCCN
CRC and NSCLC survivorship guidelines for oncology health care providers in academic and
community practice.

II. To evaluate the impact of this educational initiative on documented adherence and
compliance with NCCN guidelines for NSCLC and CRC survivorship care by oncology health care
providers.

OUTLINE:

Health care providers complete an educational intervention based on NCCN guidelines in CRC
and NSCLC survivorship care comprising a power point presentation reviewing evidence and
guidelines; a USB drive of the NCCN guidelines with paper copy of pages addressing
survivorship care; an electronic and paper copy of a sample survivorship clinic template
note with prompts for addressing survivorship care components; and an electronic paper copy
sample survivorship care plan that can be adapted and distributed at each participating
site.

Inclusion Criteria:

- HEALTH CARE PROVIDER INCLUSION CRITERIA:

- Any health care provider (physician, advanced practice clinician) at a study site
(Fox Chase Cancer Center [FCCC] and Fox Chase Cancer Center Partners [FCCCP]) who
provides care for NSCLC and/or CRC survivors

- CHART AUDIT INCLUSION CRITERIA (BASELINE):

- Cancer Registry cases include stage I-III colon cancer (adenocarcinoma histology),
stage I-III rectal cancer (adenocarcinoma histology), stage I-III non-small cell lung
cancer (squamous or adenocarcinoma histology)

- Patients must have completed all therapy for curative intent at least six months
prior to chart audit

- Undergoing routine oncology care and surveillance at the chosen site (defined as
receiving follow-up care with FCCC or FCCCP site health care providers and have an
active medical chart)

- No evidence of metastatic disease

- Patients must have been seen for a visit for cancer surveillance between 2009 and
2013

- Health care providers at the participating site must be willing and able to
participate in the educational initiative

- CHART AUDIT INCLUSION CRITERIA (POST-INTERVENTION)

- Charts eligible for audit after completion of the educational initiative will be for
those CRC and NSCLC survivors presenting for follow-up after the initiative has been
completed by site health care providers

Exclusion Criteria:

- CHART AUDIT EXCLUSION CRITERIA:

- Cancer Registry cases for diseases other than colon or rectal adenocarcinoma and
non-small cell lung cancer (squamous or adenocarcinoma histology)

- Patients currently receiving active therapy for any cancer, including CRC or NSCLC

- Patients who do not undergo routine oncologic care at the chosen Partners site or Fox
Chase Cancer Center

- Stage IV cancer or evidence of metastatic disease at any time point

- Patients who have not undergone a visit for cancer surveillance since 2009

- Fox Chase Cancer Partners sites who do not agree to chart audit procedures or
providers are unable or unwilling to participate in the educational initiative
We found this trial at
1
site
Philadelphia, Pennsylvania 19111
Principal Investigator: Crystal Denlinger, MD
Phone: 215-214-1676
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials